CDK 4/6 Inhibitors in Metastatic Breast Cancer

0 Views
administrator
administrator
07/03/23

Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next